Drug Profile
JTE 151
Alternative Names: JTE-151Latest Information Update: 08 Jun 2018
Price :
$50
*
At a glance
- Originator Orphagen Pharmaceuticals
- Developer Japan Tobacco
- Class Antiallergics
- Mechanism of Action Nuclear receptor subfamily 1 group F member 3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders; Hypersensitivity